Change language
English Deutsch
Change currency
€ EUR £ GBP $ USD
Licensed Unlicensed Requires Authentication Published by De Gruyter September 21, 2011

10% CV concentration for the fourth generation Roche cardiac troponin T assay derived from Internal Quality Control data

  • Alberto Dolci , Roberto Dominici , Paola Luraschi and Mauro Panteghini
From the journal Clinical Chemistry and Laboratory Medicine (CCLM)
https://doi.org/10.1515/CCLM.2006.267
Keywords: diagnosis; myocardial infarction; quality control; troponin
Corresponding author: Prof. Mauro Panteghini, Laboratorio Analisi Chimico-Cliniche, Ospedale “Luigi Sacco”, Via GB Grassi 74, 20157 Milano, Italy Phone +39-02-39042806, Fax +39-02-50319835,

References

1. Alpert J, Thygesen K, for the Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined – a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36:959–69.10.1016/S0735-1097(00)00804-4Search in Google Scholar

2. Panteghini M, Pagani F, Yeo KTJ, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004; 50:327–32.10.1373/clinchem.2003.026815Search in Google Scholar PubMed

3. Sheehan P, Biennerhassett J, Vasikaran SD. Decision limit for troponin I and assay performance. Ann Clin Biochem 2002; 39:231–6.10.1258/0004563021902161Search in Google Scholar PubMed

4. Hermsen D, Apple F, Garcia-Beltran L, Jaffe A, Karon B, Lewandrowski E, et al. Results from a multicenter evaluation of the 4th generation Elecsys® Troponin T assay. Clin Chem 2006; 52(Suppl):A130.Search in Google Scholar

Published Online: 2011-9-21
Published in Print: 2006-12-1

©2006 by Walter de Gruyter Berlin New York

From the journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Clinical Chemistry and Laboratory Medicine (CCLM)
Volume 44 Issue 12
Submit manuscript

Journal and Issue

Articles in the same Issue

Initiation and progression of atherosclerosis – enzymatic or oxidative modification of low-density lipoprotein?
Blood transfusions in athletes. Old dogmas, new tricks
Molecular detection of tyrosinase transcripts in peripheral blood from patients with malignant melanoma: correlation of PCR sensitivity threshold with clinical and pathologic disease characteristics
Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR
Lipoprotein lipase gene polymorphism at the PvuII locus and serum lipid levels in Guangxi Hei Yi Zhuang and Han populations
Interpretation of cardiac troponin T behaviour in size-exclusion chromatography
Point-of-care C-reactive protein testing in febrile children in general practice
Improvement in HPLC separation of porphyrin isomers and application to biochemical diagnosis of porphyrias
Measurement of late-night salivary cortisol with an automated immunoassay system
Combining markers of nephrotoxicity and hepatotoxicity for improved monitoring and detection of chronic alcohol abuse
Stone or stricture as a cause of extrahepatic cholestasis – do liver function tests predict the diagnosis?
Insulin resistance and enhanced protein glycation in men with prehypertension
Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
Variations in assay protocol for the Dako cystatin C method may change patient results by 50% without changing the results for controls
Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT)
National survey on the pre-analytical variability in a representative cohort of Italian laboratories
10% CV concentration for the fourth generation Roche cardiac troponin T assay derived from Internal Quality Control data
Biological variation of non-SI traceable biological quantities: example of proteins
Effect of tibolone therapy on lipids and coagulation indices
Acknowledgement
Contents Volume 44, 2006
Author Index
Subject Index
Downloaded on 28.4.2024 from https://www.degruyter.com/document/doi/10.1515/CCLM.2006.267/html
Scroll to top button